603127 沪市 昭衍新药

北京昭衍新药研究中心股份有限公司 2019 年股票期权与限制性
        股票激励计划预留权益授予日激励对象名单

一、 股票期权
（1）总体情况

                            获授的股票期权  占授予股票期权  占目前股本总额
  姓名          职务

                              数量（万份）    总数的比例        的比例

  孙云霞    董事、副总经理      10.8                61.71%          0.048%

  于爱水      财务总监          1                  5.71%          0.004%

核心技术（业务）骨干（8 人）      5.7                32.57%          0.025%

      合计（10 人）              17.5              100.00%          0.077%

（2）核心技术（业务）骨干

    编号                姓名                                  职务

    1                时彦胜                      核心技术（业务）骨干

    2                李洪贞                      核心技术（业务）骨干

    3                王熙                      核心技术（业务）骨干

    4                张整                      核心技术（业务）骨干

    5                蔡玉春                      核心技术（业务）骨干

    6                刘洋                      核心技术（业务）骨干

    7                刘海龙                      核心技术（业务）骨干

    8                王明明                      核心技术（业务）骨干

二、 限制性股票
（1）总体情况

                            获授的限制性股  占授予限制性股  占目前股本总额
  姓名          职务

                            票数量（万股）  票总数的比例        的比例


  顾静良      副总经理          1.5                23.81%          0.007%

  于爱水      财务总监          0.4                  6.35%          0.002%

核心技术（业务）骨干（8 人）      4.4                69.84%          0.019%

      合计（10 人）              6.3                100.00%          0.028%

（2）核心技术（业务）骨干

    编号                姓名                                  职务

    1                时彦胜                      核心技术（业务）骨干

    2                李磊                      核心技术（业务）骨干

    3                李洪贞                      核心技术（业务）骨干

    4                王熙                      核心技术（业务）骨干

    5                张整                      核心技术（业务）骨干

    6                蔡玉春                      核心技术（业务）骨干

    7                刘海龙                      核心技术（业务）骨干

    8                王明明                      核心技术（业务）骨干